Diverse populations and enrollment in pediatric cancer clinical trials: Challenges and opportunities.
Diverse populations and enrollment in pediatric cancer clinical trials: Challenges and opportunities.
复制标题
DOI:
10.1002/pbc.28296
复制
发表时间:
2020-11
影响因子:
3.2
通讯作者:
Aristizabal P
中科院分区:
文献类型:
--
作者:
Aristizabal P
Survival rates for pediatric cancer have improved significantly over the past five decades, 1 mainly due to clinical trial (CT) participation. 2 Hispanic children have a significantly higher incidence of leukemia and lymphoma; however, Hispanics and African Americans have poorer 5-year overall survival rates than their non-Hispanic White (NHW) counterparts. 3–5 Lower survival rates are at least partially attributable to lower enrollment in CTs. 6The National Institutes of Health Revitalization Act of 1993 mandated the inclusion of women and minorities in CTs. 7 However, to date, only 2% of approximately 10 000 National Cancer Institute (NCI) CTs have sufficient minority participants. 8 Despite the NCI’s efforts to include minorities in research, Hispanics and African Americans are severely underrepresented compared to NHWs (1–7% and 15% vs 67%, respectively). 8 Enrollment rates in cancer CTs are even lower at 0.4–2.2% for Hispanics and 5.4% for African Americans, even at NCI-designated cancer centers. 8 Our work demonstrated that Hispanics are underrepresented in pediatric cancer research. 9 Consequently, cancer outcomes data are primarily based on data from NHWs, providing inadequate information to adequately assess treatment benefits for minorities.
登录
查看更多内容
影响因子:
3.2
作者:
Aristizabal, Paula;Singer, Jenelle;Martinez, Maria E.
通讯作者:
Martinez, Maria E.
影响因子:
6.2
作者:
Barrett, Nadine J.;Rodriguez, Elisa M.;Gage-Bouchard, Elizabeth A.
通讯作者:
Gage-Bouchard, Elizabeth A.
影响因子:
20.3
作者:
Bhatia, S;Sather, HN;Robison, LL
通讯作者:
Robison, LL
影响因子:
28.4
作者:
Loree, Jonathan M.;Anand, Seerat;Raghav, Kanwal
通讯作者:
Raghav, Kanwal
影响因子:
8.8
作者:
Strahlendorf, Caron;Pole, Jason D.;Sung, Lillian
通讯作者:
Sung, Lillian